Cambridge Cognition Sees Major Loss Reduction

Cambridge Cognition Holdings (GB:COG) has released an update.

Cambridge Cognition Holdings PLC reports a significant reduction in adjusted operating loss to £0.1 million for the first half of 2024, down from a £2.0 million loss in the same period in 2023, thanks to steady revenues and a sharp decrease in costs. The company’s strategic focus on cognitive assessments and enhancements in commercial capabilities have poised it for growth in the estimated $700 million CNS clinical trials market. Despite challenging market conditions, the firm expects to improve its contracted order book and drive sustainable profitability and cashflow through the end of the year.

For further insights into GB:COG stock, check out TipRanks’ Stock Analysis page.